1976Archives of OphthalmologyRequires access

Treatment of Vaccinial Keratitis With Vidarabine

Robert A. Hyndiuk, Masao Okumoto, Reply Damiano, Mario J. Valenton, Gilbert Smolin

Open publisher page 29 citations

Abstract

Vaccinial epithelial keratitis was produced in rabbits. When the therapeutic effect of vidarabine on the experimentally-induced disease was evaluated and compared to the effect of idoxuridine, vidarabine was found to be highly effective, substantially more effective than idoxuridine, and nontoxic to the eye.

About this research paper

What this paper is about

Vaccinial epithelial keratitis was produced in rabbits. When the therapeutic effect of vidarabine on the experimentally-induced disease was evaluated and compared to the effect of idoxuridine, vidarabine was found to be highly effective, substantially more effective than idoxuridine, and nontoxic to the eye.

Why it matters

OpenAlex reports 29 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Vaccinial epithelial keratitis was produced in rabbits. When the therapeutic effect of vidarabine on the experimentally-induced disease was evaluated and compared to the effect of idoxuridine, vidarabine was found to be highly effective, substantially more effective than idoxuridine, and nontoxic to the eye.

Key concepts: Vidarabine, Keratitis, Medicine, Ophthalmology, Dermatology, Optometry, Surgery, Chemotherapy

Related papers

Back to paper searchBrowse research topicsOriginal source
Treatment of Vaccinial Keratitis With Vidarabine — Research Paper | ScholarLens